Liquid Biopsy as an Adjunct to Lung Screening Imaging.
Disease monitoring
Liquid biopsy
Low-dose computed tomography scan
Lung cancer screening
Journal
Thoracic surgery clinics
ISSN: 1558-5069
Titre abrégé: Thorac Surg Clin
Pays: United States
ID NLM: 101198195
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
medline:
10
10
2023
pubmed:
9
10
2023
entrez:
8
10
2023
Statut:
ppublish
Résumé
Current lung cancer screening protocols use low-dose computed tomography scans in selected high-risk individuals. Unfortunately, utilization is low, and the rate of false-positive screens is high. Peripheral biomarkers carry meaningful promise in diagnosing and monitoring cancer with added potential advantages reducing invasive procedures and improving turnaround time. Herein, the use of such blood-based assays is considered as an adjunct to further utilization and accuracy of lung cancer screening.
Identifiants
pubmed: 37806743
pii: S1547-4127(23)00033-6
doi: 10.1016/j.thorsurg.2023.04.004
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
411-419Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.